Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study-Reference-Cited by-同舟云学术

Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study

Published:2018-03-23 Issue:8 Volume:33 Page:1385-1394
ISSN:0931-041X
Container-title:Pediatric Nephrology
language:en
Short-container-title:Pediatr Nephrol

Author:

Percheron Lucas^ORCID,Gramada Raluca,Tellier Stéphanie,Salomon Remi,Harambat Jérôme,Llanas Brigitte,Fila Marc,Allain-Launay Emma,Lapeyraque Anne-Laure,Leroy Valerie,Adra Anne-Laure,Bérard Etienne,Bourdat-Michel Guylhène,Chehade Hassid,Eckart Philippe,Merieau Elodie,Piètrement Christine,Sellier-Leclerc Anne-Laure,Frémeaux-Bacchi Véronique,Dimeglio Chloe,Garnier Arnaud

Publisher

Springer Science and Business Media LLC

Subject

Nephrology,Pediatrics, Perinatology, and Child Health

Link

http://link.springer.com/article/10.1007/s00467-018-3903-9/fulltext.html

Reference38 articles.

1. Rosales A, Hofer J, Zimmerhackl L-B, Jungraithmayr TC, Riedl M, Giner T, Strasak A, Orth-Höller D, Würzner R, Karch H (2012) Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis 54:1413–1421

2. Gould LH, Demma L, Jones TF, Hurd S, Vugia DJ, Smith K, Shiferaw B, Segler S, Palmer A, Zansky S, Griffin PM (2009) Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clin Infect Dis 49:1480–1485

3. Loos S, Aulbert W, Hoppe B, Ahlenstiel-Grunow T, Kranz B, Wahl C, Staude H, Humberg A, Benz K, Kranse M, Pohl M, Liebau MC, Schild R, Lemke J, Beringer O, Müller D, Härtel C, Wigger M, Vester U, Konrad M, Haffner D, Pape L, Oh J, Kemper MJ (2017) Intermediate follow-up of pediatric patients with hemolytic uremic syndrome during the 2011 outbreak caused by E.coli O104:H4. Clin Infect Dis 64:1637–1643

4. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI (2000) The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342:1930–1936

5. Mody RK, Gu W, Griffin PM, Jones TF, Rounds J, Shiferaw B, Tobin-D’Angelo M, Smith G, Spina N, Hurd S, Lathrop S, Palmer A, Boothe E, Luna-Gierke RE, Hoekstra RM (2015) Postdiarrheal hemolytic uremic syndrome in United States children: clinical spectrum and predictors of in-hospital death. J Pediatr 166:1022–1029

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. O80:H2-Associated Hemolytic Uremic Syndrome without Hemorrhagic Colitis: A Case Report;Case Reports in Nephrology and Dialysis;2024-06-26

2. Authors' Reply: Eculizumab Seems to be a Life Saver Even in Shiga Toxin-Related Hemolytic Uremic Syndrome;Journal of the American Society of Nephrology;2024-03

3. Shiga Toxin–Producing Escherichia coli and the Hemolytic–Uremic Syndrome;New England Journal of Medicine;2023-12-28

4. Eculizumab in Shiga toxin-producing Escherichia coli hemolytic uremic syndrome: a systematic review;Pediatric Nephrology;2023-12-06

5. Eculizumab in STEC-HUS: a paradigm shift in the management of pediatric patients with neurological involvement;Pediatric Nephrology;2023-07-25